---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-000879"
form_type: "8-K"
ticker: "GALT"
cik: "0001133416"
company_name: "GALECTIN THERAPEUTICS INC"
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T02:47:18.300903+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Galectin Therapeutics updates corporate presentation; no material new disclosures

## Summary
- Filed updated corporate presentation on January 13, 2025, available on company website.
- Presentation intended for use at investor conferences and meetings.
- No specific pipeline, financial, or clinical milestones disclosed in the filing.

## SEC filing metadata
- accession: 0001140361-25-000879
- form_type: 8-K
- ticker: GALT
- cik: 0001133416
- company_name: GALECTIN THERAPEUTICS INC
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133416/000114036125000879/0001140361-25-000879-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133416/000114036125000879/ef20041348_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-000879
- JSON: https://secwatch.observer/filing/0001140361-25-000879.json
- Plain text: https://secwatch.observer/filing/0001140361-25-000879.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.